RxDoctor Payments Data

Amanda Payne

Obstetrics & Gynecology · Little Rock, ARNPI 1386060218

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations.

$4,276in general payments, 2019–2025

Across 227 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$459
  • Astellas Pharma US Inc$379
  • Bayer$361
  • Pfizer$328
  • AbbVie$324
  • Organon$318
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,276100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,276 in reported general payments places this provider in the 80th percentile of 272 obstetrics & gynecology providers in Arkansas.

See all obstetrics & gynecology providers in Arkansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
VeozahFezolinetant13$6,921
PremarinEstrogens, Conjugated33$6,527
Estradiol193$4,359
IntrarosaPrasterone (Dhea)12$3,191
DuaveeEstrogens,conj/Bazedoxifene11$2,179
Estradiol (Twice Weekly)Estradiol33$1,738
ProgesteroneProgesterone, Micronized31$1,396
ValacyclovirValacyclovir Hcl28$707
Fluconazole26$125
Metronidazole21$78
Acyclovir12$68

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin, Duavee$328$8,70644 claims
Astellas Pharma US IncVeozah$379$6,92113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 272 obstetrics & gynecology providers in Arkansas.

Other obstetrics & gynecology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →